entity

SOLANEZUMAB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SOLANEZUMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
0Hypotheses
0Analyses
6Outgoing
2Incoming

Wiki Pages (20)

Knowledge base pages for this entity

Alzheimer's Disease

disease · 5265 words

DIAN-TU-001 Trial (NCT01760005)

clinical · 4560 words

PMN310 Anti-Amyloid for AD (NCT06750432)

clinical · 4244 words

Amyloid Cascade Pathway

mechanism · 4149 words

Protein Aggregation Comparison in Neurodegeneration

mechanism · 4048 words

Outgoing (6)

TargetRelationTypeStr
CRENEZUMABassociated_withdrug0.45
TAUassociated_withprotein0.45
ADUCANUMABassociated_withdrug0.45
LECANEMABassociated_withdrug0.45
DONANEMABassociated_withdrug0.45

Incoming (2)

SourceRelationTypeStr
GANTENERUMABassociated_withdrug0.45
ad_clinical_trial_failures:solanezumabdata_indataset_row0.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found